Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
The BBRC hosts the sixth edition of the Workshop on biomarkers for neurodegenerative diseases
The event, organized together with University College London and the University of Gothenburg, is aimed at PhD students and will take place between the 15th and the 19th of May.
Arcadi Navarro receives the Award of Honor of the Telecommunications and IT Night
The Telecommunications Night Award of Honor distinguishes a public or private personality with a wide and distinguished professional career related to Electronics, Information and Communication Technologies or Audiovisual in the technical, academic, business or institutional field within the State.
28 European institutions establish new guidelines to prevent Alzheimer's
An international initiative with the participation of the BBRC has published a protocol for the creation of Brain Health Services, intended for the attention of people without cognitive impairment who wish to preserve or improve their memory.
We join the International Day of Women and Girls in Science
Three BBRC professionals give us their vision of women in the scientific field
Success of the first call for Pasqual Maragall Researchers Program scholarships with more than 60 applications received
Requests have been received from research centers in eight autonomous communities in Spain. Among the collaborators, a total of 17 researchers come from international centers.
BBRC's AlfaSleep project publishes an observational study protocol on sleep quality and its relationship with Alzheimer's disease
The research has the voluntary participation of two hundred people without cognitive impairment from the ALFA+ Study, with the support of the "la Caixa" Foundation
We found that a genetic predisposition to longer telomeres could have a protective effect against Alzheimer's
The investigations have been led by the Barcelonaβeta Brain Research Center (BBRC) and have included participants without cognitive alterations from the ALFA Study, with the support of the ”la Caixa” Foundation
Dr. Josep Maria Argimon, appointed Director of the Scientific Infrastructure of the Barcelonaβeta Brain Research Center
The Research Center of the Pasqual Maragall Foundation incorporates Dr. Argimon to lead the development and management of its research infrastructures, studies and cohorts.
A new research drug against Alzheimer's confirms its positive results during CTAD
The results, published in The New England Journal of Medicine, confirm that lecanemab slows cognitive decline by 27% in patients in the early stages of Alzheimer's disease.
